Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor canal block: effect of 10 vs 30 ml ropivacaine on quadriceps strength in healthy volunteers
2013-003522-83Phase 4Completed
- Sponsor
- Professor Jørgen B. Dahl
- Start
- Oct 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Professor Jørgen B. Dahl. Primary endpoint: Quadriceps strength reduction >25% (primary). Started Oct 2013; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2013-003522-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003522-83.